bioMérieux S.A. (EPA:BIM)
116.40
-0.50 (-0.43%)
Mar 28, 2025, 5:35 PM CET
bioMérieux Revenue
In the year 2024, bioMérieux had annual revenue of 3.98B EUR with 8.31% growth. bioMérieux had revenue of 2.08B in the half year ending December 31, 2024, with 7.61% growth.
Revenue
3.98B
Revenue Growth
+8.31%
P/S Ratio
3.44
Revenue / Employee
275.41K
Employees
13,982
Market Cap
13.73B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.98B | 305.20M | 8.31% |
Dec 31, 2023 | 3.67B | 85.60M | 2.39% |
Dec 31, 2022 | 3.59B | 212.90M | 6.31% |
Dec 31, 2021 | 3.38B | 258.00M | 8.27% |
Dec 31, 2020 | 3.12B | 443.40M | 16.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionbioMérieux News
- 21 days ago - bioMérieux S.A. (BMXMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript - Seeking Alpha
- 3 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
- 3 years ago - bioMérieux: Pioneering In Vitro Diagnostics - Seeking Alpha
- 4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha